The significant discovery focused on improving the degradation of aggregation-prone proteins involved in neurodegenerative diseases, ultimately leading to a start-up company focused on developing targeted treatments.
The OnCue Keyboard challenges the notion of accessibility, providing a playful yet functional design tailored for those with Parkinson's disease and hand mobility issues.
"It provides patients with another option to alleviate their motor fluctuations that are commonly experienced with levodopa (the best drug we have so far in Parkinson's) in the moderate to advanced stages of the disorder," Fernandez told Fox News Digital.